Roche Holding AG (RHHBY)
40.14
-0.02
(-0.05%)
USD |
OTCM |
Sep 27, 16:00
Roche Research and Development Expense (Annual): 15.81B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.81B |
| December 31, 2022 | 15.96B |
| December 31, 2021 | 16.19B |
| December 31, 2020 | 13.88B |
| December 31, 2019 | 12.86B |
| December 31, 2018 | 12.36B |
| December 31, 2017 | 11.46B |
| December 31, 2016 | 11.71B |
| December 31, 2015 | 9.956B |
| December 31, 2014 | 10.83B |
| December 31, 2013 | 10.00B |
| December 31, 2012 | 10.19B |
| December 31, 2011 | 9.424B |
| Date | Value |
|---|---|
| December 31, 2010 | 9.577B |
| December 31, 2009 | 9.121B |
| December 31, 2008 | 8.188B |
| December 31, 2007 | 6.992B |
| December 31, 2006 | 5.882B |
| December 31, 2005 | 4.559B |
| December 31, 2004 | 4.155B |
| December 31, 2003 | 3.545B |
| December 31, 2002 | 2.744B |
| December 31, 2001 | 2.309B |
| December 31, 2000 | 2.341B |
| December 31, 1999 | 2.520B |
| December 31, 1998 | 2.355B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
12.86B
Minimum
2019
16.19B
Maximum
2021
14.94B
Average
15.81B
Median
2023
Research and Development Expense (Annual) Benchmarks
| Eli Lilly and Co | 9.313B |
| Novo Nordisk AS | 4.710B |
| Novartis AG | 11.37B |
| Johnson & Johnson | 15.08B |
| Pfizer Inc | 10.68B |